UCSF

Tagged: Research

Classroom pharmacogenetics, post-hospital medications, and post-brain-surgery drugs take top honors

Studies of pharmacogenetics testing of pharmacy students as a teaching tool, an improved system to resolve medication issues after patients go home from the hospital, and the prophylactic use of an antiseizure drug for brain surgery patients took top honors at the Department of Clinical Pharmacy 18th Annual Spring Research Seminar.

Stebbins, Cocohoba leading specialty drug study with Walgreens

So-called specialty drugs can represent lifesaving advances in the treatment of serious complex conditions, such as cancers, hepatitis C, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. They can turn once routinely lethal diseases such as HIV and cystic fibrosis into manageable chronic conditions. They can address rare genetic conditions, such as hemophilia, or suppress immune rejection after organ transplants.

Podcast: Comparison Shopping For Health Care?

Health Affairs

Burchard Lab study finds most asthma research may not apply to African American children

Results from the largest single study of the genetic and environmental causes of asthma in African American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population.

UC San Francisco limb growth study looks at bats

The Mercury News

If 1 in 10 U.S. Smokers Quits, $63 Billion Saved

U.S. News & World Report

Health care spending drops quickly with reduced smoking

A new study lead-authored by UCSF School of Pharmacy faculty member James Lightwood, PhD, has found that reducing smoking cuts health care spending, not just in the long- or immediate-term, but the very next year.

For example, the analysis found that a 10 percent decline in smoking in the United States would be followed by an expected $63 billion reduction (in 2012 U.S. dollars) in national health care spending the following year.

Pages